Cargando…

MAP4K1 expression is a novel resistance mechanism and independent prognostic marker in AML-but can be overcome via targeted inhibition

Detalles Bibliográficos
Autores principales:	Knight, Tristan E., Edwards, Holly, Taub, Jeffrey W., Ge, Yubin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8318977/ https://www.ncbi.nlm.nih.gov/pubmed/34280781 http://dx.doi.org/10.1016/j.ebiom.2021.103488

Ejemplares similares

Evaluating venetoclax and its potential in treatment-naïve acute myeloid leukemia
por: Knight, Tristan, et al.
Publicado: (2019)

“FLipping” the Story: FLT3-Mutated Acute Myeloid Leukemia and the Evolving Role of FLT3 Inhibitors
por: Knight, Tristan E., et al.
Publicado: (2022)

The combination of CUDC-907 and gilteritinib shows promising in vitro and in vivo antileukemic activity against FLT3-ITD AML
por: Qiao, Xinan, et al.
Publicado: (2021)

Overcoming bias and systematic errors in next generation sequencing data
por: Taub, Margaret A, et al.
Publicado: (2010)

Panobinostat Enhances Cytarabine and Daunorubicin Sensitivities in AML Cells through Suppressing the Expression of BRCA1, CHK1, and Rad51
por: Xie, Chengzhi, et al.
Publicado: (2013)

Simultaneous cotargeting of ATR and RNA Polymerase I transcription demonstrates synergistic antileukemic effects on acute myeloid leukemia
por: Wang, Tingting, et al.
Publicado: (2019)

Tackling TKI resistance in AML: A commentary on “Inhibition of BCL2A1 by STAT5 inactivation overcomes resistance to targeted therapies of FLT3-ITD/D835 mutant AML.” by Yamatani et al.
por: Hatırnaz Ng, Özden, et al.
Publicado: (2022)

Antileukemic activity and mechanism of action of the novel PI3K and histone deacetylase dual inhibitor CUDC-907 in acute myeloid leukemia
por: Li, Xinyu, et al.
Publicado: (2019)

Challenges in stem cell-derived islet replacement therapy can be overcome
por: Abdulreda, Midhat H., et al.
Publicado: (2021)

Histone deacetylases 1 and 2 cooperate in regulating BRCA1, CHK1, and RAD51 expression in acute myeloid leukemia cells
por: Zhao, Jianyun, et al.
Publicado: (2016)

Overcoming the Blues: Can Managing Depressive Symptoms Improve Access to Kidney Transplantation?
por: Plantinga, Laura C., et al.
Publicado: (2022)

R-2-HG in AML… friend or foe?
por: Elf, Shannon Elisabeth, et al.
Publicado: (2021)

The antagonistic duality of NPM1 mutations in AML
por: Khan, Irum, et al.
Publicado: (2022)

Can Thyroid Hormone Analogues Be Used to Overcome Hypomyelination and Demyelination of the Central Nervous System?
por: Cullen, Carlie L., et al.
Publicado: (2017)

The HDAC and PI3K dual inhibitor CUDC-907 synergistically enhances the antileukemic activity of venetoclax in preclinical models of acute myeloid leukemia
por: Li, Xinyu, et al.
Publicado: (2020)

SPINK2 Protein Expression Is an Independent Adverse Prognostic Marker in AML and Is Potentially Implicated in the Regulation of Ferroptosis and Immune Response
por: Pitts, Herbert Augustus, et al.
Publicado: (2023)

American Society of Hematology 2020 Podcast Collection: MDS and AML
por: Almeida, António
Publicado: (2021)

Neurological prognostication after cardiac arrest: how the “Best CPC” project would overcome selection biases
por: Paul, Marine, et al.
Publicado: (2019)

Personalising cancer medicine with prognostic markers
por: Kerr, David J, et al.
Publicado: (2021)

Prediction of competing endogenous RNA coexpression network as prognostic markers in AML
por: Wang, Jun-Dan, et al.
Publicado: (2019)

Identification of CD318 (CDCP1) as novel prognostic marker in AML
por: Heitmann, Jonas S., et al.
Publicado: (2020)

Commentary: “I can see clearly now!” Indocyanine green virtual-assisted lung mapping (ICG-VAL-MAP) and the future identification of small lung nodules
por: Beqari, Jorind, et al.
Publicado: (2021)

Inhibition of XPO1 enhances cell death induced by ABT‐199 in acute myeloid leukaemia via Mcl‐1
por: Luedtke, Daniel A., et al.
Publicado: (2018)

Targeting ERK enhances the cytotoxic effect of the novel PI3K and mTOR dual inhibitor VS-5584 in preclinical models of pancreatic cancer
por: Ning, Changwen, et al.
Publicado: (2017)

Overcoming physical barriers in cancer therapy
por: Beyer, Ines, et al.
Publicado: (2013)

Interchangeability of Biosimilars: Overcoming the Final Hurdles
por: Barbier, Liese, et al.
Publicado: (2021)

Copeptin: a new and promising diagnostic and prognostic marker
por: Katan, Mira, et al.
Publicado: (2008)

Overexpression of GATA1 Confers Resistance to Chemotherapy in Acute Megakaryocytic Leukemia
por: Caldwell, John Timothy, et al.
Publicado: (2013)

Inhibition of CHK1 enhances cell death induced by the Bcl-2-selective inhibitor ABT-199 in acute myeloid leukemia cells
por: Zhao, Jianyun, et al.
Publicado: (2016)

A standardized microarray assay for the independent gene expression markers in AML: EVI1 and BAALC
por: Brand, Jaap, et al.
Publicado: (2013)

Calcitonin receptor‐like (CALCRL) is a marker of stemness and an independent predictor of outcome in pediatric AML
por: Angenendt, Linus, et al.
Publicado: (2021)

Expanding the scope of candidate prognostic marker IGFBP2 in glioblastoma
por: Lindström, Mikael S.
Publicado: (2019)

Treatment options for adult intermediate-risk AML patients in CR1: Allo-HSCT or chemotherapy?
por: Wang, Luxiang, et al.
Publicado: (2023)

Enhancing anti-AML activity of venetoclax by isoflavone ME-344 through suppression of OXPHOS and/or purine biosynthesis
por: Hurrish, Katie H., et al.
Publicado: (2023)

Co-Targeting the EGFR and PI3K/Akt Pathway to Overcome Therapeutic Resistance in Head and Neck Squamous Cell Carcinoma: What about Autophagy?
por: Zaryouh, Hannah, et al.
Publicado: (2022)

CHK1 plays a critical role in the anti-leukemic activity of the wee1 inhibitor MK-1775 in acute myeloid leukemia cells
por: Qi, Wenxiu, et al.
Publicado: (2014)

Panobinostat Synergistically Enhances the Cytotoxic Effects of Cisplatin, Doxorubicin or Etoposide on High-Risk Neuroblastoma Cells
por: Wang, Guan, et al.
Publicado: (2013)

Overcoming Resistance to FLT3 Inhibitors in the Treatment of FLT3-Mutated AML
por: Lam, Stephen S.Y., et al.
Publicado: (2020)

The Role of Vitamin D as a Prognostic Marker in Papillary Thyroid Cancer
por: Bains, Ashank, et al.
Publicado: (2021)

The role of leadership in overcoming staff turnover in critical care
por: Roy, Kelly, et al.
Publicado: (2005)

Cannot write session to /tmp/vufind_sessions/sess_mqrnpnocjplogo2f04f2i3mbob